John Valliant Fusion Pharmaceuticals Inc. (FUSN) insider trading activity

FUSN Quotes by TradingView

John Valliant is Chief Executive Officer of Fusion Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of FUSN, which is worth approximately $0. The most recent transaction as insider was on Mar 16, 2022, when has been sold 100 shares (Common Stock) at a price of $6.99 per share, resulting in proceeds of $699. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

John Valliant Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 16 2022
SELL
Open market or private sale
$699 $6.99 p/Share
100 Reduced 0.03%
385,964 Common Stock
Mar 15 2022
SELL
Open market or private sale
$712 $7.12 p/Share
100 Reduced 0.03%
386,064 Common Stock
Mar 14 2022
SELL
Open market or private sale
$9,048 $6.96 p/Share
1,300 Reduced 0.34%
386,164 Common Stock
Mar 11 2022
SELL
Open market or private sale
$713 $7.13 p/Share
100 Reduced 0.03%
387,464 Common Stock
Mar 10 2022
SELL
Open market or private sale
$13,414 $7.06 p/Share
1,900 Reduced 0.49%
387,564 Common Stock
Mar 09 2022
SELL
Open market or private sale
$5,705 $6.94 p/Share
822 Reduced 0.21%
389,464 Common Stock
Mar 08 2022
SELL
Open market or private sale
$20,788 $6.92 p/Share
3,004 Reduced 0.76%
390,286 Common Stock
Mar 07 2022
SELL
Open market or private sale
$21,669 $6.99 p/Share
3,100 Reduced 0.78%
393,290 Common Stock
Mar 04 2022
SELL
Open market or private sale
$61,488 $7.32 p/Share
8,400 Reduced 2.08%
396,390 Common Stock
Mar 03 2022
SELL
Open market or private sale
$1,456 $7.28 p/Share
200 Reduced 0.05%
404,790 Common Stock
Mar 02 2022
SELL
Open market or private sale
$197,502 $7.44 p/Share
26,546 Reduced 6.15%
404,990 Common Stock
Mar 01 2022
SELL
Open market or private sale
$6,242 $7.37 p/Share
847 Reduced 0.2%
431,536 Common Stock
Feb 28 2022
SELL
Open market or private sale
$22,940 $7.4 p/Share
3,100 Reduced 0.71%
432,383 Common Stock
Feb 25 2022
SELL
Open market or private sale
$61,711 $7.57 p/Share
8,152 Reduced 1.84%
435,483 Common Stock
Feb 24 2022
SELL
Open market or private sale
$18,525 $7.41 p/Share
2,500 Reduced 0.56%
443,635 Common Stock
Feb 23 2022
SELL
Open market or private sale
$227,653 $7.77 p/Share
29,299 Reduced 6.16%
446,135 Common Stock
Feb 22 2022
SELL
Open market or private sale
$32,185 $7.85 p/Share
4,100 Reduced 0.85%
475,434 Common Stock
Feb 18 2022
SELL
Open market or private sale
$38,596 $7.88 p/Share
4,898 Reduced 1.01%
479,534 Common Stock
Feb 17 2022
SELL
Open market or private sale
$13,566 $7.98 p/Share
1,700 Reduced 0.35%
484,432 Common Stock
Feb 16 2022
SELL
Open market or private sale
$265,284 $7.99 p/Share
33,202 Reduced 6.39%
486,132 Common Stock
Feb 15 2022
SELL
Open market or private sale
$104,958 $8.33 p/Share
12,600 Reduced 2.37%
519,334 Common Stock
JV

John Valliant

Chief Executive Officer
Hamilton, A6

Track Institutional and Insider Activities on FUSN

Follow Fusion Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FUSN shares.

Notify only if

Insider Trading

Get notified when an Fusion Pharmaceuticals Inc. insider buys or sells FUSN shares.

Notify only if

News

Receive news related to Fusion Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FUSN